To the Editor: A recent article highlighted a case where self‐collection enabled detection of an early cervical adenocarcinoma and curative treatment in a previously underscreened woman.1 This case underlines the important benefits from self‐collection making cervical screening more accessible and acceptable to women who have previously declined or delayed screening.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. McGauran MF, Pendlebury A. HPV swab self‐collection and cervical cancer in women who have sex with women. Med J Aust 2020; 212: 106–107. https://www.mja.com.au/journal/2020/212/3/hpv-swab-self-collection-and-cervical-cancer-women-who-have-sex-women.
- 2. Australian Institute of Health and Welfare. Cervical screening in Australia 2018 (Cat. No. CAN 111). Canberra: AIHW, 2018. https://www.aihw.gov.au/getmedia/8a26b34d-a912-4f01-b646-dc5d0ca54f03/aihw-can-111.pdf.aspx?inline=true (viewed July 2020).
- 3. Saville M, Hawkes D, Mclachlan E, et al. Self‐collection for under‐screened women in a National Cervical Screening Program: pilot study. Curr Oncol 2018; 25: e27–e32.
- 4. Sultana F, Roeske L, Malloy MJ, et al. Implementation of Australia's renewed cervical screening program: preparedness of general practitioners and nurses. PLoS One 2020; 15: e0228042.
- 5. Arbyn M, Smith SB, Temin S, et al. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta‐analyses. BMJ 2018; 363: k4823.
Megan Smith receives salary support from the National Health and Medical Research Council (APP1159491) and Cancer Institute NSW (ECF181561). The funders played no role in the planning, writing or publication of this letter.
Marion Saville is Executive Director of VCS Foundation, which runs VCS Pathology, one of two laboratories in Australia accredited to process self‐collected samples.